Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha

Author: Kalgutkar Amit S.   Chen Danny   Varma Manthena V.   Feng Bo   Terra Steven G.   Scialis Renato J.   Rotter Charles J.   Frederick Kosea S.   West Mark A.   Goosen Theunis C.   Gosset James R.   Walsky Robert L.   Francone Omar L.  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.43, Iss.11, 2013-11, pp. : 963-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content